New research findings shows that specific bacteria in patients’ gut microbiome correlate with biomarkers that suggest they are at greater risk of heart damage during chemotherapy.  

98 women over the age of 60 diagnosed with breast cancer were tested for biomarkers that indicate heart health and their gut bacteria genome was sequenced before chemotherapy. 

This study is part of a wider project called CARDIOCARE which will allow the research to expand to a larger study of 600 women to confirm the finding. This work offers the hope that tailored probiotics could be used to help protect women from the heart side-effects of chemotherapy in future. 

This article provides an overview of recent advancements in tissue engineering and regenerative medicine, highlighting various innovations in biomaterials, therapeutic strategies, and diagnostic technologies. It covers topics such as the development of minimally invasive implantable materials for bone regeneration, the construction of photo-responsive implant materials, the application of artificial ligaments in ACL reconstruction, and the exploration of active components in traditional Chinese medicine for treating osteoporosis.